TT Insider: David Regnery Exercises Options and Sells 22,497 Shares

Rhea-AI Filing Summary

Trane Technologies (TT) insider activity: Director and Chair/CEO David S. Regnery executed transactions on 09/02/2025 under a Rule 10b5-1 trading plan. He acquired 22,497 ordinary shares by exercising stock options at a conversion/exercise price of $62.53 per share, and concurrently disposed of 22,497 ordinary shares at a reported price of $410 per share. After these transactions his beneficial ownership decreased from 146,209.941 to 123,712.941 ordinary shares. The option referenced vested in pro rata installments beginning February 7, 2018.

Positive

• Transaction executed under a Rule 10b5-1 plan, indicating prearranged trading and reduced regulatory risk
• Options were vested (vesting began February 7, 2018), showing the exercised rights were earned over time

Negative

• Beneficial ownership decreased from 146,209.941 to 123,712.941 shares following the transactions

Insights

Corporate Governance Expert

TL;DR: CEO executed a 10b5-1 plan sale after exercising vested options, reducing beneficial ownership by 22,497 shares.

The filing shows a routine, preplanned insider transaction under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when properly adopted. The CEO exercised options priced at $62.53 and sold the same number of shares at a reported price of $410, lowering his beneficial stake from 146,209.941 to 123,712.941 shares. This pattern—exercise followed by sale under a 10b5-1 plan—is common for liquidity and tax planning and is documented with vesting commencing in 2018. No amendment or other governance irregularities are evident in the form.

Securities Analyst

TL;DR: Insider exercised options and sold identical shares under a documented plan; transaction is material to insider holdings but not to company fundamentals.

The report quantifies a reduction of ~15.4% of the reported pre-transaction beneficial holdings (22,497 of 146,209.941). The exercise price of $62.53 and reported sale price of $410 imply a large per-share spread for the insider, though the Form 4 does not provide aggregate proceeds or reasons beyond the 10b5-1 plan reference. From a market-impact perspective, the disclosed sale size is modest relative to a large-cap issuer but is clearly material to the reporting person’s ownership. No changes to compensation structure or unusual derivative positions are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regnery David S

(Last) (First) (Middle)

C/O TRANE TECHNOLOGIES COMPANY LLC

800-E BEATY STREET

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trane Technologies plc [ TT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/02/2025		M		22,497	A	$62.53	146,209.941	D
Ordinary Shares	09/02/2025		S		22,497(1)	D	$410	123,712.941	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$62.53	09/02/2025		M			22,497	(2)	02/06/2027	Ordinary Shares	22,497	$0	0	D

Explanation of Responses:

1. Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 2, 2025.

2. The stock option vested in three (3) pro rata annual installments beginning on February 7, 2018.

Remarks:

	/s/ Eric R. Waller, Attorney-in-Fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Trane Technologies (TT) report on 09/02/2025?

Director and CEO David S. Regnery exercised 22,497 stock option rights at $62.53 and sold 22,497 ordinary shares at a reported price of $410 per share under a Rule 10b5-1 plan.

How did the transactions affect the insider's holdings in TT?

Beneficial ownership declined from 146,209.941 shares to 123,712.941 shares after the reported transactions.

Were the option rights fully vested at the time of exercise?

The filing states the stock option vested in three pro rata annual installments beginning on February 7, 2018.

Was the sale part of a pre-established trading plan?

Yes. The sale was executed pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2025.

Who signed the Form 4 on behalf of the reporting person?

The form was signed by Eric R. Waller, Attorney-in-Fact on 09/03/2025.